ARTICLE | Company News
NicOx, Topigen COPD deal
October 28, 2005 3:10 AM UTC
NicOx (Euronext:Nicox) granted Topigen (Montreal, Quebec) North American rights to develop and commercialize NCX 1020 for chronic obstructive pulmonary disease (COPD) and other respiratory disorders. ...